Prenetics Global Ltd - Class A
Research Prenetics Global Ltd - Class A (PRE) on Bullrun: market cap USD 389.00M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPRE
- ExchangeNASDAQ
- CountryHong Kong
- SectorConsumer Defensive
- IndustryPackaged Foods
- CurrencyUSD
- Market capUSD 389.00M
- Financial periodQ1 2026
- RevenueUSD 35.95M
- Net income-USD 23.10M
- Free cash flow-USD 12.12M
- Gross margin64.8%
Valuation Snapshot
latest market cap is USD 389.00M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 95.11M | -USD 37.71M | n/a | 52.8% | -4.95 | USD 32.13M | USD 1.77M | USD 156.46M |
| FY2024 | USD 35.03M | -USD 45.97M | n/a | 44.2% | -6.05 | USD 52.25M | USD 5.77M | USD 170.39M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 389.00M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 265.77M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 74.50M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 71.03M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 237.67M | n/a | n/a | n/a |
About Prenetics Global Ltd - Class A
Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
What is Prenetics Global Ltd - Class A's market cap?
Prenetics Global Ltd - Class A's market capitalization is USD 389.00M.
What does Prenetics Global Ltd - Class A do?
Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.